nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.06.2001 | Review Article

Drug-Induced Urticaria

Recognition and Treatment

verfasst von: Debbie Shipley, Dr Anthony D. Ormerod

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 3/2001

Einloggen, um Zugang zu erhalten

Abstract

Urticaria is the second most common cutaneous manifestation of drug allergy. Drug-induced urticaria is seen in 0.16% of medical inpatients and accounts for 9% of chronic urticaria or angioedema seen in dermatology outpatient departments. Occurring within 24 hours of drug ingestion, it is most commonly caused by penicillins, sulfonamides and nonsteroidal anti-inflammatory drugs.

Drug-induced urticaria is seen in association with anaphylaxis, angioedema, and serum sickness. Diagnosis requires a detailed history, knowledge of the most likely agents sometimes supplemented with in vitro and skin testing. For mild reactions, avoidance of the causative drug and treatment with antihistamines will suffice. For anaphylactic shock, treatment with epinephrine (adrenaline), corticosteroids and antihistamines is required. Patients should be educated to inform medical staff about previous drug reactions, and to avoid these and cross-reacting drugs if possible. Medical staff need to routinely enquire about allergy and avoid unnecessary prescriptions.

Sharma V.K., Kaur I., Vatve M., et al. Rifampicin-induced urticaria in leprosy. Leprosy Rev 1997; 68 (4): 331–332PubMed

Gupta A.K., Lynde C.W., Lauzon G.J., et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature]. Br J Dermatol 1998; 138 (3): 529–532PubMedCrossRef

Demoly P., Messaad D., Trylesinski A., et al. Nelfinavir-induced urticaria and successful desensitization. J Allergy Clin Immunol 1998; 102 (5): 875–876PubMedCrossRef

Kainer M.A., Mijch A. Anaphylactoid reaction, angioedema, and urticaria associated with lamivudine. Lancet 1996; 348 (9040): 1519PubMedCrossRef

Demoly P., Messaad D., Fabre J., et al. Nevirapine-induced cutaneous hypersensitivity reactions and successful tolerance induction. J Allergy Clin Immunol 1999; 104 (2 Pt 1): 504–505PubMedCrossRef

Smith H.R., Croft A.M., Black M.M. Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports. Clin Exp Dermatol 1999; 24 (4): 249–254PubMedCrossRef

Bolognia J.L. Cutaneous ulceration: an unusual complication of intravenous pentamidine therapy. Dermatologica 1991; 183 (3): 221–224PubMedCrossRef

van Puyenbroek E., Stricker B.H. Hypersensitivity reactions to use of mebeverine. Nederlands Tijdschrift voor Geneeskunde 1997; 141 (28): 1392–1395PubMed

Sancho Calabuig A., Palop Larrea V., Lopez Gonzalez E., et al. Ranitidine and a rare adverse reaction: urticaria. Spanish. Atencion Primaria 1997; 20 (7): 396–397

10.

Schneider S., Hebuterne X., Chichmanian R.M., et al. Urticaria caused by omeprazole. Gastroenterologie Clinique et Biologique 1994; 18 (5): 534–535PubMed

11.

Warner D.M., Ramos-Caro F.A., Flowers F.P. Famotidine (pepcid)-induced symptomatic dermatographism. J Am Acad Dermatol 1994; 31 (4): 677–6778PubMedCrossRef

12.

Phillips E., Knowles S., Weber E., et al. Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. J Allergy Clin Immunol 1998; 102 (4 Pt 1): 697–698PubMedCrossRef

13.

Mora-Fernandez C., Navarro J.F., Macia M. Urticarial anaphylactoid reaction following metoprolol [letter]. Clin Nephrol 1997; 47 (3): 203PubMed

14.

Frye C.B., Pettigrew T.J. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy 1998; 18 (4): 866–868PubMed

15.

Rivera J.O. Losartan-induced angioedema. Ann Pharmacother 1999; 33 (9): 933–935PubMedCrossRef

16.

Wutschert R., Piletta P., Bounameaux H. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Saf 1999; 20 (6): 515–525PubMedCrossRef

17.

Weinmann P., Moretti J.L., Leynadier F. Anaphylaxis-like reaction induced by dipyridamole during myocardial scintigraphy. Am J Med 1994; 97 (5): 488PubMedCrossRef

18.

Rudolf J., Grond M., Prince W.S., et al. Evidence of anaphylaxy after alteplase infusion. Stroke 1999; 30 (5): 1142–1143PubMedCrossRef

19.

Toubi E., Seligmann H., Golan T.D. Bezalip-induced anaphylaxis. Ann Allergy Asthma Immunol 1995; 75 (4): 370PubMed

20.

Roger D., Rolle F., Mausset J., et al. Urticarial vasculitis induced by fluoxetine [letter]. Dermatology 1995; 191 (2): 164PubMedCrossRef

21.

Dachs R., Vitillo J. Angioedema associated with sumatriptan administration. Am J Med 1995; 99 (6): 684–685PubMedCrossRef

22.

Tripathi A., Greenberger P.A. Bupropion hydrochloride induced serum sicknesslike reaction. Ann Allergy Asthma Immunol 1999; 83 (2): 165–166PubMedCrossRef

23.

Ciesielski-Carlucci C., Leong P., Jacobs C. Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles. Am J Clin Oncol 1997; 20 (4): 373–375PubMedCrossRef

24.

Larzilliere I., Brandissou S., Breton P., et al. Anaphylactic reaction to oxaliplatin: a case report. Am J Gastroenterol 1999; 94 (11): 3387–3388PubMedCrossRef

25.

Rubeiz N.G., Salem Z., Dibbs R., et al. Bleomycin-induced urticarial flagellate drug hypersensitivity reaction. Int J Dermatol 1999; 38 (2): 140–141PubMedCrossRef

26.

Bourry C., Naveau C., Lazrak K., et al. First case of urticaria due to dacarbazine. Therapie 1995; 50 (6): 588–589PubMed

27.

al-Lamki Z., Thomas E., el-Banna N., et al. Acute urticaria and hepatitis complicating high-dose methotrexate therapy. Med Pediatr Oncol 1995; 24 (2): 137–140PubMedCrossRef

28.

Sakaguchi M., Inouye S. Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines. Vaccine 1998; 16 (1): 68–69PubMedCrossRef

29.

Sakaguchi M., Nakayama T., Inouye S. Cases of systemic immediate-type urticaria associated with acellular diphtheria-tetanus-pertussis vaccination. Vaccine 1998; 16 (11–12): 1138–1140PubMedCrossRef

30.

Barbaud A., Trechot P., Reichert-Penetrat S., et al. Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol 1998; 139 (5): 925–926PubMedCrossRef

31.

Valvano M.N., Martin T.P. Periorbital urticaria and topical fluorescein. Am J Emerg Med 1998; 16 (5): 525–526PubMedCrossRef

32.

Koehler I.K. Acute immediate urticarialike reaction to i.v. injected photofrin. Lasers Surg Med 1997; 20 (1): 97–98PubMedCrossRef

33.

Bech-Thomsen N., Wulf H.C. 8-Methoxypsoralen urticaria. J Am Acad Dermatol 1994; 31 (6): 1063–1064PubMedCrossRef

34.

Hunziker T., Kunzi U.P., Braunschweig S., et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52 (4): 388–393PubMedCrossRef

35.

Bigby M., Jick S., Jick H., et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256 (24): 3358–3363PubMedCrossRef

36.

Stubb S., Heikkila H., Kauppinen K. Cutaneous reactions to drugs: a series of in-patients during a five-year period. Acta Derm Venereol 1994; 74 (4): 289–291PubMed

37.

Asero R. Aspirin and paracetamol tolerance in patients with nimesulide- induced urticaria. Ann Allergy Asthma Immunol 1998; 81 (3): 237–238PubMedCrossRef

38.

Anderson M.W., deShazo R.D. Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine. J Allergy Clin Immunol 1990; 85 (5): 856–858PubMedCrossRef

39.

Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331 (19): 1272–1285PubMedCrossRef

40.

Kozel M.M., Mekkes J.R., Bossuyt P.M., et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134 (12): 1575–1580PubMedCrossRef

41.

Turner A.N., Whittaker S., Banks S., et al. Plasma exchange in refractory cutaneous vasculitis. Br J Dermatol 1990; 122: 411–415PubMedCrossRef

42.

Doeglas H.M. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975; 93 (2): 135–144PubMedCrossRef

43.

Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981; 104 (4): 369–381PubMedCrossRef

44.

Humphreys F., Hunter J.A. The characteristics of urticaria in 390 patients. Br J Dermatol 1998; 138 (4): 635–638PubMedCrossRef

45.

Moscicki R.A., Fox R., Kailasam V., et al. Astemizole, steroid sparing effect in urticaria. J Allergy Clin Immunol 1992; 89: 249

46.

Breathnach S.M. Mechanisms of drug eruptions: Part I. Austral J Dermatol 1995; 36 (3): 121–127CrossRef

47.

Wintroub B.U., Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol 1985; 13 (2 Pt 1): 167–179PubMedCrossRef

48.

Gaig P., San Miguel M.M., Enrique E., et al. Selective type-1 hypersensitivity to cefixime. Allergy 1999; 54 (8): 901–902PubMedCrossRef

49.

Pichichero M.E., Pichichero D.M. Selecting skin testing reagents to predict amoxicillin and cephalosporin allergy. Pediatr Asthma Allergy Immunol 1997; 11 (2): 79–93CrossRef

50.

Monroe E.W., Cohen S.H., Kalbfleisch J., et al. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981; 117: 404–407PubMedCrossRef

51.

Garcia J.J., Blanca M., Moreno F., et al. Determination of IgE antibodies to the benzylpenicilloyl determinant: a comparison of the sensitivity and specificity of three radio allergo sorbent test methods. J Clin Lab Anal 1997; 11 (5): 251–257PubMedCrossRef

52.

Goldfine A.B., Kahn C.R. Insulin allergy and insulin resistance. Curr Ther Endocrinol Metab 1994; 5: 461–464PubMed

53.

Skov L., Hansen H., Dittmar H.C., et al. Susceptibility to effects of UVB irradiation on induction of contact sensitivity, relevance of number and function of Langerhans cells and epidermal macrophages. Photochem Photobiol 1998; 67 (6): 714–719PubMedCrossRef

54.

Nolte H., Schiotz O., Skov P.S. A new glass microfibre-based histamine analysis for allergy testing in children. Results compared with conventional leukocyte histamine release assay, skin prick test, bronchial provocation test and RAST. Allergy 1987; 42 (5): 366–373PubMedCrossRef

55.

Ordoqui E., Zubeldia J.M., Aranzabal A., et al. Serum tryptase levels in adverse drug reactions. Allergy 1997; 52 (11): 1102–1105PubMedCrossRef

56.

Sullivan T.J., Wedner H.J., Shatz G.S., et al. Skin testing to detect penicillin allergy. J Allergy Clin Immunol 1981; 68 (3): 171–180CrossRef

57.

Sogn D.D., Evans R., III, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152 (5): 1025–1032PubMedCrossRef

58.

Blanca M., Torres M.J., Garcia J.J., et al. Natural evolution of skin test sensitivity in patients allergic to beta- lactam antibiotics. J Allergy Clin Immunol 1999; 103 (5 Pt 1): 918–924PubMedCrossRef

59.

Barbaud A., Reichert-Penetrat S., Trechot P., et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139 (1): 49–58PubMedCrossRef

60.

Quiralte J., Blanco C., Castillo R., et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98 (3): 678–685PubMedCrossRef

61.

Vieluf D., Przybilla B., Schwerbrock U., et al. Oral provocation test in the diagnosis of anaphylactoid reactions to ‘mild’ analgesic preparations. Int Arch Allergy Immunol 1995; 107 (1-3): 268–271PubMedCrossRef

62.

Hein U.R., Chantraine-Hess S., Worm M., et al. Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions, Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients, Biphasic systemic anaphylaxis: an inpatient and outpatient study. Acta Derm Venereol 1999; 79 (2): 139–142PubMedCrossRef

63.

Martin-Munoz F., Moreno-Ancillo A., Dominguez-Noche C., et al. Evaluation of drug-related hypersensitivity reactions in children. J Invest Allergol Clin Immunol 1999; 9 (3): 172–177

64.

Ballmer-Weber B.K., Gex-Collet C., Wuthrich B. Inhibition of histamine or allergeninduced wheals by a single dose of acrivastine, fexofenadine or cetirizine. J Investig Allergol Clin Immunol 1999 Nov–Dec; 9 (6): 351–355PubMed

65.

Zuberbier T., Ifflander J., Semmler C., et al. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venerol 1996 Jul; 76 (4): 295–297PubMed

66.

Runge J.W., Martinez J.C., Caravati E.M., et al. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 1992 Mar; 21 (3): 237–242PubMedCrossRef

67.

Douglas D.M., Sukenick E., Andrade W.P., et al. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994; 93 (6): 977–985PubMedCrossRef

68.

Project team of the resuscitation council Emergency treatment of anaphylaxis. J Accident Emerg Med 2000; 16: 243–247

69.

Grzelewska-Rzymowska I., Roznlecki J., Szmidt M. Aspirin ‘desensitization’ in patients with aspirin-induced urticaria and angioedema. Allergologia Immunopathol 1988; 16 (5): 305–308

70.

Stark B.J., Earl H.S., Gross G.N., et al. Acute and chronic desensitization of penicillinallergic patients using oral penicillin. J Allergy Clin Immunol 1987; 79 (3): 523–532PubMedCrossRef

71.

Borish L., Tamir R., Rosenwasser L.J. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987; 80 (3 Pt 1): 314–319PubMedCrossRef

72.

Rowinsky E.K., Donehower R.C. Paclitaxel (taxol). N Engl J Med 1995; 332 (15): 1004–1014PubMedCrossRef

73.

Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30 (8): 1144–1150PubMedCrossRef

Titel: Drug-Induced Urticaria
Recognition and Treatment
verfasst von: Debbie Shipley
Dr Anthony D. Ormerod
Publikationsdatum: 01.06.2001
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 3/2001
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.2165/00128071-200102030-00004

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2001

Estrogen and Skin

Simultaneous Onset of Psoriasis Vulgaris in Monozygotic Twins

Psoriasis of the Scalp

Optimal Management of Acne to Prevent Scarring and Psychological Sequelae

Topical Eflornithine